FILE - This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Monday, Nov. 13, 2017, the FDA approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd.
FILE - This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Monday, Nov. 13, 2017, the FDA approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Andrew Harnik, File AP Photo
FILE - This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Monday, Nov. 13, 2017, the FDA approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Andrew Harnik, File AP Photo

US regulators approve first digital pill to track patients

November 14, 2017 02:24 PM

UPDATED November 14, 2017 06:57 PM

More Videos

  • A lighthearted look at Black Friday madness

    More than 90 million people take advantage of Black Friday deals, undeterred by the fact that more people are injured or killed in shopping-related accidents than by sharks each year. Here’s a look at last year's madness of Black Friday shopping at stores nationwide.